Optimizing outcomes of colorectal cancer surgery with robotic platforms
- PMID: 33839441
- DOI: 10.1016/j.suronc.2021.101559
Optimizing outcomes of colorectal cancer surgery with robotic platforms
Erratum in
-
Optimizing outcomes of colorectal cancer surgery with robotic platforms.Surg Oncol. 2022 Aug;43:101786. doi: 10.1016/j.suronc.2022.101786. Epub 2022 Jun 8. Surg Oncol. 2022. PMID: 35688695
Abstract
Advanced robotic technology makes it easier to perform total mesorectal excision procedures in the narrow pelvis for rectal cancer while maintaining the advantages of minimally invasive surgery. Robotic surgery for rectal cancer leads to lower conversion rates and faster recovery of urogenital function than conventional laparoscopic surgery. However, longer operative time and high cost are major weaknesses of robotic surgery. To date, most other short-term surgical outcomes, pathologic outcomes, and long-term oncologic outcomes of robotic surgery have not shown significant advantages over laparoscopic surgery. However, robotic surgery is still a valid and highly anticipated surgical approach for rectal cancer because it greatly reduces the surgeon's workload and learning curve. There are also advantages when robotic techniques are applied to technically demanding procedures such as lateral pelvic lymph node dissection or intersphincteric resection. The introduction of new surgical robot systems, including the da Vinci® SP system, is expected to expand the applications of robotic surgery and provide new advantages.
Keywords: Colorectal neoplasm; Minimally invasive surgery; Robotic surgery.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
